Kera Capital Partners Inc. Invests $245,000 in Mettler-Toledo International Inc. (NYSE:MTD)

Kera Capital Partners Inc. bought a new stake in Mettler-Toledo International Inc. (NYSE:MTD) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 200 shares of the medical instruments supplier’s stock, valued at approximately $245,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. International Assets Investment Management LLC raised its holdings in Mettler-Toledo International by 149,870.0% in the 3rd quarter. International Assets Investment Management LLC now owns 89,982 shares of the medical instruments supplier’s stock valued at $134,946,000 after acquiring an additional 89,922 shares during the period. Canoe Financial LP lifted its position in shares of Mettler-Toledo International by 576.5% during the 4th quarter. Canoe Financial LP now owns 55,518 shares of the medical instruments supplier’s stock worth $67,936,000 after buying an additional 47,311 shares during the last quarter. Retirement Systems of Alabama increased its position in Mettler-Toledo International by 610.4% during the 3rd quarter. Retirement Systems of Alabama now owns 33,462 shares of the medical instruments supplier’s stock worth $50,183,000 after purchasing an additional 28,752 shares in the last quarter. JPMorgan Chase & Co. grew its position in Mettler-Toledo International by 14.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock worth $332,634,000 after acquiring an additional 28,478 shares during the last quarter. Finally, Wellington Management Group LLP raised its holdings in Mettler-Toledo International by 17.5% in the 3rd quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock valued at $266,891,000 after buying an additional 26,443 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at $314,820. This trade represents a 24.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gerry Keller sold 140 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total value of $175,572.60. Following the completion of the transaction, the insider now directly owns 6 shares in the company, valued at $7,524.54. This represents a 95.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Trading Down 0.1 %

Shares of MTD opened at $1,295.77 on Friday. The business’s 50 day moving average is $1,241.52 and its 200 day moving average is $1,344.05. Mettler-Toledo International Inc. has a 12-month low of $1,133.46 and a 12-month high of $1,546.93. The company has a market capitalization of $27.34 billion, a PE ratio of 34.94, a price-to-earnings-growth ratio of 3.83 and a beta of 1.12.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on MTD. Wells Fargo & Company dropped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a report on Monday, November 11th. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Evercore ISI raised Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Finally, Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. One analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.